Breast cancer risks associated with missense variants in breast cancer susceptibility genes

Leila Dorling, Sara Carvalho, Jamie Allen, Michael T. Parsons, Cristina Fortuno, Anna González-Neira, Stephan M. Heijl, Muriel A. Adank, Thomas U. Ahearn, Irene L. Andrulis, Päivi Auvinen, Heiko Becher, Matthias W. Beckmann, Sabine Behrens, Marina Bermisheva, Natalia V. Bogdanova, Stig E. Bojesen, Manjeet K. Bolla, Michael Bremer, Ignacio Briceno, Nicola J. Camp, Archie Campbell, Jose E. Castelao, Jenny Chang-Claude, Stephen J. Chanock, Georgia Chenevix-Trench, NBCS Collaborators, J. Margriet Collée, Kamila Czene, Joe Dennis, Thilo Dörk, Mikael Eriksson, D. Gareth Evans, Peter A. Fasching, Jonine Figueroa, Henrik Flyger, Marike Gabrielson, Manuela Gago-Dominguez, Montserrat García-Closas, Graham G. Giles, Gord Glendon, Pascal Guénel, Melanie Gündert, Andreas Hadjisavvas, Eric Hahnen, Per Hall, Ute Hamann, Elaine F. Harkness, Mikael Hartman, Frans B.L. Hogervorst, Antoinette Hollestelle, Reiner Hoppe, Anthony Howell, kConFab Investigators, SGBCC Investigators, Anna Jakubowska, Audrey Jung, Elza Khusnutdinova, Sung-Won Kim, Yon-Dschun Ko, Vessela N. Kristensen, Inge M.M. Lakeman, Jingmei Li, Annika Lindblom, Maria A. Loizidou, Artitaya Lophatananon, Jan Lubiński, Craig Luccarini, Michael J. Madsen, Arto Mannermaa, Mehdi Manoochehri, Sara Margolin, Dimitrios Mavroudis, Roger L. Milne, Nur Aishah Mohd Taib, Kenneth Muir, Heli Nevanlinna, William G. Newman, Jan C. Oosterwijk, Sue K. Park, Paolo Peterlongo, Paolo Radice, Emmanouil Saloustros, Elinor J. Sawyer, Rita K. Schmutzler, Mitul Shah, Xueling Sim, Melissa C. Southey, Harald Surowy, Maija Suvanto, Ian Tomlinson, Diana Torres, Thérèse Truong, Christi J. van Asperen, Regina Waltes, Qin Wang, Xiaohong R. Yang, Paul D.P. Pharoah, Marjanka K. Schmidt, Javier Benitez, Bas Vroling, Alison M. Dunning, Soo Hwang Teo, Anders Kvist, Miguel de la Hoya, Peter Devilee, Amanda B. Spurdle, Maaike P.G. Vreeswijk, Douglas F. Easton
doi: https://doi.org/10.1101/2021.09.02.21262369

Article Information

doi 
https://doi.org/10.1101/2021.09.02.21262369
History 
  • September 15, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Leila Dorling1,*,
  2. Sara Carvalho1,
  3. Jamie Allen1,
  4. Michael T. Parsons2,
  5. Cristina Fortuno2,
  6. Anna González-Neira3,
  7. Stephan M. Heijl4,
  8. Muriel A. Adank5,
  9. Thomas U. Ahearn6,
  10. Irene L. Andrulis7,8,
  11. Päivi Auvinen9,10,11,
  12. Heiko Becher12,
  13. Matthias W. Beckmann13,
  14. Sabine Behrens14,
  15. Marina Bermisheva15,
  16. Natalia V. Bogdanova16,17,18,
  17. Stig E. Bojesen19,20,21,
  18. Manjeet K. Bolla1,
  19. Michael Bremer16,
  20. Ignacio Briceno22,
  21. Nicola J. Camp23,
  22. Archie Campbell24,25,
  23. Jose E. Castelao26,
  24. Jenny Chang-Claude14,27,
  25. Stephen J. Chanock6,
  26. Georgia Chenevix-Trench2,
  27. NBCS Collaborators28,29,30,31,32,33,34,35,36,
  28. J. Margriet Collée37,
  29. Kamila Czene38,
  30. Joe Dennis1,
  31. Thilo Dörk17,
  32. Mikael Eriksson38,
  33. D. Gareth Evans39,40,41,42,
  34. Peter A. Fasching13,43,
  35. Jonine Figueroa6,25,44,
  36. Henrik Flyger45,
  37. Marike Gabrielson38,
  38. Manuela Gago-Dominguez46,47,
  39. Montserrat García-Closas6,
  40. Graham G. Giles48,49,50,
  41. Gord Glendon7,
  42. Pascal Guénel51,
  43. Melanie Gündert52,53,54,
  44. Andreas Hadjisavvas55,56,
  45. Eric Hahnen57,58,
  46. Per Hall38,59,
  47. Ute Hamann60,
  48. Elaine F. Harkness41,42,61,
  49. Mikael Hartman62,63,64,
  50. Frans B.L. Hogervorst5,
  51. Antoinette Hollestelle65,
  52. Reiner Hoppe66,67,
  53. Anthony Howell42,68,
  54. kConFab Investigators69,70,
  55. SGBCC Investigators62,63,71,72,73,74,75,76,77,78,79,80,81,
  56. Anna Jakubowska82,83,
  57. Audrey Jung14,
  58. Elza Khusnutdinova15,84,
  59. Sung-Won Kim85,
  60. Yon-Dschun Ko86,
  61. Vessela N. Kristensen29,35,
  62. Inge M.M. Lakeman87,
  63. Jingmei Li64,71,
  64. Annika Lindblom88,89,
  65. Maria A. Loizidou55,56,
  66. Artitaya Lophatananon90,
  67. Jan Lubiński82,
  68. Craig Luccarini91,
  69. Michael J. Madsen23,
  70. Arto Mannermaa9,92,93,
  71. Mehdi Manoochehri60,
  72. Sara Margolin59,94,
  73. Dimitrios Mavroudis95,
  74. Roger L. Milne48,49,50,
  75. Nur Aishah Mohd Taib96,97,
  76. Kenneth Muir90,
  77. Heli Nevanlinna98,
  78. William G. Newman39,40,42,
  79. Jan C. Oosterwijk99,
  80. Sue K. Park100,101,102,
  81. Paolo Peterlongo103,
  82. Paolo Radice104,
  83. Emmanouil Saloustros105,
  84. Elinor J. Sawyer106,
  85. Rita K. Schmutzler57,58,107,
  86. Mitul Shah91,
  87. Xueling Sim62,
  88. Melissa C. Southey48,50,108,
  89. Harald Surowy52,53,
  90. Maija Suvanto98,
  91. Ian Tomlinson109,110,
  92. Diana Torres60,111,
  93. Thérèse Truong51,
  94. Christi J. van Asperen112,
  95. Regina Waltes17,
  96. Qin Wang1,
  97. Xiaohong R. Yang6,
  98. Paul D.P. Pharoah1,91,
  99. Marjanka K. Schmidt113,114,
  100. Javier Benitez3,115,
  101. Bas Vroling4,116,
  102. Alison M. Dunning91,
  103. Soo Hwang Teo97,117,
  104. Anders Kvist118,
  105. Miguel de la Hoya119,
  106. Peter Devilee87,120,
  107. Amanda B. Spurdle2,
  108. Maaike P.G. Vreeswijk87 and
  109. Douglas F. Easton1,91
  1. 1Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK
  2. 2Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, 4006, Australia
  3. 3Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, 28029, Spain
  4. 4Bio-Prodict, Nijmegen, The Netherlands
  5. 5Family Cancer Clinic, The Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Amsterdam, 1066 CX, The Netherlands
  6. 6Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, 20850, USA
  7. 7Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, M5G 1X5, Canada
  8. 8Department of Molecular Genetics, University of Toronto, Toronto, ON, M5S 1A8, Canada
  9. 9Translational Cancer Research Area, University of Eastern Finland, Kuopio, 70210, Finland
  10. 10Institute of Clinical Medicine, Oncology, University of Eastern Finland, Kuopio, 70210, Finland
  11. 11Department of Oncology, Cancer Center, Kuopio University Hospital, Kuopio, 70210, Finland
  12. 12Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany
  13. 13Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, 91054, Germany
  14. 14Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany
  15. 15Institute of Biochemistry and Genetics, Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, 450054, Russia
  16. 16Department of Radiation Oncology, Hannover Medical School, Hannover, 30625, Germany
  17. 17Gynaecology Research Unit, Hannover Medical School, Hannover, 30625, Germany
  18. 18N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, 223040, Belarus
  19. 19Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, 2730, Denmark
  20. 20Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, 2730, Denmark
  21. 21Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, 2200, Denmark
  22. 22Medical Faculty, Universidad de La Sabana, Bogota, 140013, Colombia
  23. 23Department of Internal Medicine and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, 84112, USA
  24. 24Centre for Genomic and Experimental Medicine, MRC Institute of Genetics & Molecular Medicine, The University of Edinburgh, Western General Hospital, Edinburgh, EH4 2XU, UK
  25. 25Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, EH16 4UX, UK
  26. 26Oncology and Genetics Unit, Instituto de Investigacion Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, Vigo, 36312, Spain
  27. 27Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany
  28. 28Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Oslo, 0379, Norway
  29. 29Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, 0450, Norway
  30. 30Department of Research, Vestre Viken Hospital, Drammen, 3019, Norway
  31. 31Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Oslo, 0379, Norway
  32. 32Department of Oncology, Division of Surgery, Cancer and Transplantation Medicine, Oslo University Hospital-Radiumhospitalet, Oslo, 0379, Norway
  33. 33Department of Oncology, Akershus University Hospital, Lørenskog, 1478, Norway
  34. 34Breast Cancer Research Consortium, Oslo University Hospital, Oslo, 0379, Norway
  35. 35Department of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, 0379, Norway
  36. 36Department of Community Medicine, The Arctic University of Norway, Tromsø, 9037, Norway
  37. 37Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, 3015 CN, The Netherlands
  38. 38Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, 171 65, Sweden
  39. 39Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9WL, UK
  40. 40North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, M13 9WL, UK
  41. 41Nightingale & Genesis Prevention Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, M23 9LT, UK
  42. 42NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, M13 9WL, UK
  43. 43David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, CA, 90095, USA
  44. 44Cancer Research UK Edinburgh Centre, The University of Edinburgh, Edinburgh, EH4 2XR, UK
  45. 45Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, 2730, Denmark
  46. 46Fundación Pública Galega de Medicina Xenómica, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, 15706, Spain
  47. 47Moores Cancer Center, University of California San Diego, La Jolla, CA, 92037, USA
  48. 48Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, 3004, Australia
  49. 49Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, 3010, Australia
  50. 50Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, 3168, Australia
  51. 51Center for Research in Epidemiology and Population Health (CESP), Team Exposome and Heredity, INSERM, University Paris-Saclay, Villejuif, 94805, France
  52. 52Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany
  53. 53Molecular Biology of Breast Cancer, University Womens Clinic Heidelberg, University of Heidelberg, Heidelberg, 69120, Germany
  54. 54Institute of Diabetes Research, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, 85764, Germany
  55. 55Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, Nicosia, 2371, Cyprus
  56. 56Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology & Genetics, Nicosia, 2371, Cyprus
  57. 57Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, 50937, Germany
  58. 58Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, 50937, Germany
  59. 59Department of Oncology, Södersjukhuset, Stockholm, 118 83, Sweden
  60. 60Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany
  61. 61Division of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK
  62. 62Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, 119077, Singapore
  63. 63Department of Surgery, National University Health System, Singapore, 119228, Singapore
  64. 64Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119077, Singapore
  65. 65Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, 3015 GD, The Netherlands
  66. 66Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, 70376, Germany
  67. 67University of Tübingen, Tübingen, 72074, Germany
  68. 68Division of Cancer Sciences, University of Manchester, Manchester, M13 9PL, UK
  69. 69Research Department, Peter MacCallum Cancer Center, Melbourne, Victoria, 3000, Australia
  70. 70Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, 3000, Australia
  71. 71Human Genetics Division, Genome Institute of Singapore, Singapore, 138672, Singapore
  72. 72Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore, 119077, Singapore
  73. 73Cancer Genetics Service, National Cancer Centre, Singapore, 169610, Singapore
  74. 74Breast Department, KK Women’s and Children’s Hospital, Singapore, 229899, Singapore
  75. 75SingHealth Duke-NUS Breast Centre, Singapore, 168753, Singapore
  76. 76Department of General Surgery, Tan Tock Seng Hospital, Singapore, 308433, Singapore
  77. 77Division of Surgical Oncology, National Cancer Centre, Singapore, 169610, Singapore
  78. 78Department of General Surgery, Singapore General Hospital, Singapore, 169608, Singapore
  79. 79Division of Breast Surgery, Department of General Surgery, Changi General Hospital, Singapore, 529889, Singapore
  80. 80Division of Radiation Oncology, National Cancer Centre, Singapore, 169610, Singapore
  81. 81Division of Medical Oncology, National Cancer Centre, Singapore, 169610, Singapore
  82. 82Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, 71-252, Poland
  83. 83Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, 71-252, Poland
  84. 84Department of Genetics and Fundamental Medicine, Bashkir State University, Ufa, 450000, Russia
  85. 85Department of Surgery, Daerim Saint Mary’s Hospital, Seoul, 07442, Korea
  86. 86Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, 53113, Germany
  87. 87Department of Human Genetics, Leiden University Medical Center, Leiden, 2333 ZA, The Netherlands
  88. 88Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, 171 76, Sweden
  89. 89Department of Clinical Genetics, Karolinska University Hospital, Stockholm, 171 76, Sweden
  90. 90Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PL, UK
  91. 91Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, CB1 8RN, UK
  92. 92Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, 70210, Finland
  93. 93Biobank of Eastern Finland, Kuopio University Hospital, Kuopio, Finland
  94. 94Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, 118 83, Sweden
  95. 95Department of Medical Oncology, University Hospital of Heraklion, Heraklion, 711 10, Greece
  96. 96Breast Cancer Research Unit, University Malaya Cancer Research Institute, Faculty of Medicine, University of Malaya, Kuala Lumpur, 50603, Malaysia
  97. 97Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, 50603, Malaysia
  98. 98Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, 00290, Finland
  99. 99Department of Genetics, University Medical Center Groningen, University Groningen, Groningen, 9713 GZ, The Netherlands
  100. 100Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, 03080, Korea
  101. 101Convergence Graduate Program in Innovative Medical Science, Seoul National University College of Medicine, Seoul, 03080, South Korea
  102. 102Cancer Research Institute, Seoul National University, Seoul, 03080, Korea
  103. 103Genome Diagnostics Program, IFOM - the FIRC Institute of Molecular Oncology, Milan, 20139, Italy
  104. 104Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, 20133, Italy
  105. 105Department of Oncology, University Hospital of Larissa, Larissa, 411 10, Greece
  106. 106School of Cancer & Pharmaceutical Sciences, Comprehensive Cancer Centre, Guy’s Campus, King’s College London, London, UK
  107. 107Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, 50931, Germany
  108. 108Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, 3010, Australia
  109. 109Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, B15 2TT, UK
  110. 110Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, OX3 7BN, UK
  111. 111Institute of Human Genetics, Pontificia Universidad Javeriana, Bogota, 110231, Colombia
  112. 112Department of Clinical Genetics, Leiden University Medical Center, Leiden, 2333 ZA, The Netherlands
  113. 113Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, 1066 CX, The Netherlands
  114. 114Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Amsterdam, 1066 CX, The Netherlands
  115. 115Biomedical Network on Rare Diseases (CIBERER), Madrid, 28029, Spain
  116. 116Centre for Molecular and Biomolecular Informatics (CMBI), Radboud University Medical Center, Nijmegen, The Netherlands
  117. 117Breast Cancer Research Programme, Cancer Research Malaysia, Subang Jaya, Selangor, 47500, Malaysia
  118. 118Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, 22381, Sweden
  119. 119Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, 28040, Spain
  120. 120Department of Pathology, Leiden University Medical Center, Leiden, 2333 ZA, The Netherlands
  1. ↵*Corresponding author: ld429{at}medschl.cam.ac.uk
Back to top
Posted September 15, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Breast cancer risks associated with missense variants in breast cancer susceptibility genes
Leila Dorling, Sara Carvalho, Jamie Allen, Michael T. Parsons, Cristina Fortuno, Anna González-Neira, Stephan M. Heijl, Muriel A. Adank, Thomas U. Ahearn, Irene L. Andrulis, Päivi Auvinen, Heiko Becher, Matthias W. Beckmann, Sabine Behrens, Marina Bermisheva, Natalia V. Bogdanova, Stig E. Bojesen, Manjeet K. Bolla, Michael Bremer, Ignacio Briceno, Nicola J. Camp, Archie Campbell, Jose E. Castelao, Jenny Chang-Claude, Stephen J. Chanock, Georgia Chenevix-Trench, NBCS Collaborators, J. Margriet Collée, Kamila Czene, Joe Dennis, Thilo Dörk, Mikael Eriksson, D. Gareth Evans, Peter A. Fasching, Jonine Figueroa, Henrik Flyger, Marike Gabrielson, Manuela Gago-Dominguez, Montserrat García-Closas, Graham G. Giles, Gord Glendon, Pascal Guénel, Melanie Gündert, Andreas Hadjisavvas, Eric Hahnen, Per Hall, Ute Hamann, Elaine F. Harkness, Mikael Hartman, Frans B.L. Hogervorst, Antoinette Hollestelle, Reiner Hoppe, Anthony Howell, kConFab Investigators, SGBCC Investigators, Anna Jakubowska, Audrey Jung, Elza Khusnutdinova, Sung-Won Kim, Yon-Dschun Ko, Vessela N. Kristensen, Inge M.M. Lakeman, Jingmei Li, Annika Lindblom, Maria A. Loizidou, Artitaya Lophatananon, Jan Lubiński, Craig Luccarini, Michael J. Madsen, Arto Mannermaa, Mehdi Manoochehri, Sara Margolin, Dimitrios Mavroudis, Roger L. Milne, Nur Aishah Mohd Taib, Kenneth Muir, Heli Nevanlinna, William G. Newman, Jan C. Oosterwijk, Sue K. Park, Paolo Peterlongo, Paolo Radice, Emmanouil Saloustros, Elinor J. Sawyer, Rita K. Schmutzler, Mitul Shah, Xueling Sim, Melissa C. Southey, Harald Surowy, Maija Suvanto, Ian Tomlinson, Diana Torres, Thérèse Truong, Christi J. van Asperen, Regina Waltes, Qin Wang, Xiaohong R. Yang, Paul D.P. Pharoah, Marjanka K. Schmidt, Javier Benitez, Bas Vroling, Alison M. Dunning, Soo Hwang Teo, Anders Kvist, Miguel de la Hoya, Peter Devilee, Amanda B. Spurdle, Maaike P.G. Vreeswijk, Douglas F. Easton
medRxiv 2021.09.02.21262369; doi: https://doi.org/10.1101/2021.09.02.21262369
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area